Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
NCT06562621
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma Multiforme
Gliomas, Malignant
Interventions
BIOLOGICAL:
ON-01
DRUG:
ONF
Sponsor
Beijing Neurosurgical Institute